131 related articles for article (PubMed ID: 33517305)
21. Selective coexpression of VEGF receptor 2 in EGFRvIII-positive glioblastoma cells prevents cellular senescence and contributes to their aggressive nature.
Jones KA; Gilder AS; Lam MS; Du N; Banki MA; Merati A; Pizzo DP; VandenBerg SR; Gonias SL
Neuro Oncol; 2016 May; 18(5):667-78. PubMed ID: 26420897
[TBL] [Abstract][Full Text] [Related]
22. Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas.
Wang Q; Tan Y; Fang C; Zhou J; Wang Y; Zhao K; Jin W; Wu Y; Liu X; Liu X; Kang C
Aging (Albany NY); 2019 Sep; 11(18):7707-7722. PubMed ID: 31532757
[TBL] [Abstract][Full Text] [Related]
23. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
24. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
25. Complex oncogenic signaling networks regulate brain tumor-initiating cells and their progenies: pivotal roles of wild-type EGFR, EGFRvIII mutant and hedgehog cascades and novel multitargeted therapies.
Mimeault M; Batra SK
Brain Pathol; 2011 Sep; 21(5):479-500. PubMed ID: 21615592
[TBL] [Abstract][Full Text] [Related]
26. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.
Eskilsson E; Rosland GV; Talasila KM; Knappskog S; Keunen O; Sottoriva A; Foerster S; Solecki G; Taxt T; Jirik R; Fritah S; Harter PN; Välk K; Al Hossain J; Joseph JV; Jahedi R; Saed HS; Piccirillo SG; Spiteri I; Leiss L; Euskirchen P; Graziani G; Daubon T; Lund-Johansen M; Enger PØ; Winkler F; Ritter CA; Niclou SP; Watts C; Bjerkvig R; Miletic H
Neuro Oncol; 2016 Dec; 18(12):1644-1655. PubMed ID: 27286795
[TBL] [Abstract][Full Text] [Related]
27. Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.
Kastenhuber ER; Huse JT; Berman SH; Pedraza A; Zhang J; Suehara Y; Viale A; Cavatore M; Heguy A; Szerlip N; Ladanyi M; Brennan CW
Acta Neuropathol; 2014 May; 127(5):747-59. PubMed ID: 24292886
[TBL] [Abstract][Full Text] [Related]
28. Expression of miRNA-21, miRNA-107, miRNA-137 and miRNA-29b in meningioma.
Katar S; Baran O; Evran S; Cevik S; Akkaya E; Baran G; Antar V; Hanimoglu H; Kaynar MY
Clin Neurol Neurosurg; 2017 May; 156():66-70. PubMed ID: 28349893
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningioma.
Dorward NL; Hawkins RA; Whittle IR
Br J Neurosurg; 1993; 7(2):197-9. PubMed ID: 8388222
[TBL] [Abstract][Full Text] [Related]
30. TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
Biczok A; Kraus T; Suchorska B; Terpolilli NA; Thorsteinsdottir J; Giese A; Tonn JC; Schichor C
J Neurooncol; 2018 Sep; 139(3):671-678. PubMed ID: 29808339
[TBL] [Abstract][Full Text] [Related]
31.
Bakas S; Akbari H; Pisapia J; Martinez-Lage M; Rozycki M; Rathore S; Dahmane N; O'Rourke DM; Davatzikos C
Clin Cancer Res; 2017 Aug; 23(16):4724-4734. PubMed ID: 28428190
[No Abstract] [Full Text] [Related]
32. The molecular biology of hormone and growth factor receptors in meningiomas.
Black P; Carroll R; Zhang J
Acta Neurochir Suppl; 1996; 65():50-3. PubMed ID: 8738495
[TBL] [Abstract][Full Text] [Related]
33. Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma.
Kuratsu JI; Seto H; Kochi M; Ushio Y
Acta Neurochir (Wien); 1994; 131(3-4):289-93. PubMed ID: 7754837
[TBL] [Abstract][Full Text] [Related]
34. Ribozyme-mediated inhibition of 801-bp deletion-mutant epidermal growth factor receptor mRNA expression in glioblastoma multiforme.
Karpel-Massler G; Wirtz CR; Halatsch ME
Molecules; 2010 Jun; 15(7):4670-8. PubMed ID: 20657384
[TBL] [Abstract][Full Text] [Related]
35. Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes.
Stec WJ; Rosiak K; Siejka P; Peciak J; Popeda M; Banaszczyk M; Pawlowska R; Treda C; Hulas-Bigoszewska K; Piaskowski S; Stoczynska-Fidelus E; Rieske P
Oncotarget; 2016 May; 7(22):31907-25. PubMed ID: 27004406
[TBL] [Abstract][Full Text] [Related]
36. Expression of estrogen receptors alpha and beta in human meningiomas.
Carroll RS; Zhang J; Black PM
J Neurooncol; 1999 Apr; 42(2):109-16. PubMed ID: 10421067
[TBL] [Abstract][Full Text] [Related]
37. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis.
Liu Z; Han L; Dong Y; Tan Y; Li Y; Zhao M; Xie H; Ju H; Wang H; Zhao Y; Zheng Q; Wang Q; Su J; Fang C; Fu S; Jiang T; Liu J; Li X; Kang C; Ren H
Oncotarget; 2016 Jan; 7(4):4680-94. PubMed ID: 26717039
[TBL] [Abstract][Full Text] [Related]
38. The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis.
Hoogstrate Y; Ghisai SA; de Wit M; de Heer I; Draaisma K; van Riet J; van de Werken HJG; Bours V; Buter J; Vanden Bempt I; Eoli M; Franceschi E; Frenel JS; Gorlia T; Hanse MC; Hoeben A; Kerkhof M; Kros JM; Leenstra S; Lombardi G; Lukacova S; Robe PA; Sepulveda JM; Taal W; Taphoorn M; Vernhout RM; Walenkamp AME; Watts C; Weller M; de Vos FYF; Jenster GW; van den Bent M; French PJ
Neuro Oncol; 2022 Mar; 24(3):429-441. PubMed ID: 34608482
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway.
Johnson MD; O'Connell MJ; Pilcher W; Reeder JE
J Neurosurg; 2010 May; 112(5):934-9. PubMed ID: 19698046
[TBL] [Abstract][Full Text] [Related]
40. Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas.
Viana-Pereira M; Lopes JM; Little S; Milanezi F; Basto D; Pardal F; Jones C; Reis RM
Anticancer Res; 2008; 28(2A):913-20. PubMed ID: 18507036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
